I agree. There is no need to compromise on this. However, the product has been registered in many other countries around the world. What's stopping Canada from registering it in a decent period of time? It's becoming indecent. We would need two antiviral drugs, with distinct effects, on the market.
Don't you agree?
If there is no issue, what's happening? Is the delay due to lack of staff to do the right thing? There must be a problem, since it has been approved in many other countries around the world.